News & Updates

SOF/VEL combo improves well-being of children with CHC
SOF/VEL combo improves well-being of children with CHC
27 Apr 2025 byStephen Padilla

In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.

SOF/VEL combo improves well-being of children with CHC
27 Apr 2025